ONTOLOGY REPORT - ANNOTATIONS
| Term: | 3,3',4,4',5-pentachlorobiphenyl |
|
| Accession: | CHEBI:34317
|
browse the term
|
| Definition: | A pentachlorobiphenyl that has formula C12H5Cl5. |
| Synonyms: | exact_synonym: | 3,3',4,4',5-pentachloro-1,1'-biphenyl |
| | related_synonym: | 3,4,5,3',4'-Penta coplanar polychlorinated biphenyl; C12H5Cl5; Clc1ccc(cc1Cl)-c1cc(Cl)c(Cl)c(Cl)c1; InChI=1S/C12H5Cl5/c13-8-2-1-6(3-9(8)14)7-4-10(15)12(17)11(16)5-7/h1-5H; InChIKey=REHONNLQRWTIFF-UHFFFAOYSA-N; PCB 126 |
| | xref_casrn: | 57465-28-8 |
| | xref: | ChEMBL:327468 "ChEMBL COMPOUND"; ChemIDplus:57465-28-8 "CAS Registry Number"; KEGG COMPOUND:57465-28-8 "CAS Registry Number"; KEGG COMPOUND:C14573 "KEGG COMPOUND" |
| | xref_mesh: | MESH:C023035 |
| | xref: | NIST Chemistry WebBook:57465-28-8 "CAS Registry Number" |
|
|
3,3',4,4',5-pentachlorobiphenyl
|
| G |
A2m |
alpha-2-macroglobulin |
|
decreases expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Aadat |
aminoadipate aminotransferase |
|
decreases expression |
EXP |
16 |
32,845,006 |
32,885,600 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
affects expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
multiple interactions |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
decreases expression |
EXP |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
increases expression |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
multiple interactions |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
affects expression |
ISO |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
increases expression |
EXP |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
affects expression |
ISO |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Acsbg2 |
acyl-CoA synthetase bubblegum family member 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
ISO |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acsm2a |
acyl-CoA synthetase medium-chain family member 2A |
|
multiple interactions |
EXP |
1 |
177,830,613 |
177,869,061 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
decreases expression |
EXP |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actl7b |
actin-like 7b |
|
decreases expression |
ISO |
5 |
74,646,523 |
74,647,911 |
RGD:6480464 |
CTD |
| G |
Actrt2 |
actin-related protein T2 |
|
decreases expression |
ISO |
5 |
171,473,765 |
171,475,165 |
RGD:6480464 |
CTD |
| G |
Acy1 |
aminoacylase 1 |
|
decreases expression |
EXP |
8 |
111,576,888 |
111,581,571 |
RGD:6480464 |
CTD |
| G |
Adamtsl2 |
ADAMTS-like 2 |
|
increases expression |
ISO |
3 |
5,976,490 |
6,004,532 |
RGD:6480464 |
CTD |
| G |
Adamtsl5 |
ADAMTS-like 5 |
|
decreases expression |
ISO |
7 |
10,874,586 |
10,879,783 |
RGD:6480464 |
CTD |
| G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
decreases expression |
EXP |
2 |
235,749,346 |
235,765,063 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
affects expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
decreases expression |
EXP |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
decreases expression |
EXP |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
decreases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
increases expression |
ISO |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
decreases expression |
EXP |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects binding |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects binding |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects binding |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects binding |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects response to substance |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
increases expression |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
increases expression |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
increases expression |
ISO |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
decreases expression |
EXP |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
decreases expression |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
multiple interactions |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
decreases expression |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
decreases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
decreases expression |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
decreases expression |
EXP |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Aoc2-ps1 |
amine oxidase, copper containing 2 (retina-specific), pseudogene 1 |
|
decreases expression |
ISO |
10 |
90,352,884 |
90,354,299 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
decreases expression |
EXP |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
decreases expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
decreases expression |
EXP |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
|
increases expression |
ISO |
15 |
27,412,068 |
27,433,673 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
decreases expression |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Aspg |
asparaginase homolog (S. cerevisiae) |
|
decreases expression |
EXP |
6 |
136,909,407 |
136,928,801 |
RGD:6480464 |
CTD |
| G |
Atp6v0e2 |
ATPase, H+ transporting V0 subunit e2 |
|
increases expression |
ISO |
4 |
76,621,828 |
76,624,976 |
RGD:6480464 |
CTD |
| G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
decreases expression |
EXP |
7 |
67,120,782 |
67,127,697 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
decreases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
decreases expression |
ISO |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C1qtnf5 |
C1q and tumor necrosis factor related protein 5 |
|
decreases expression |
ISO |
8 |
47,089,564 |
47,091,434 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
decreases expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
multiple interactions |
EXP |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
decreases expression |
EXP |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car8 |
carbonic anhydrase 8 |
|
affects expression |
ISO |
5 |
21,951,255 |
22,049,427 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
affects expression |
ISO |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cc2d1b |
coiled-coil and C2 domain containing 1B |
|
affects expression |
ISO |
5 |
129,906,965 |
129,920,984 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
decreases expression |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
multiple interactions |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccs |
copper chaperone for superoxide dismutase |
|
affects expression |
ISO |
1 |
207,429,928 |
207,450,996 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
EXP |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
affects expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
increases expression |
EXP |
18 |
56,756,511 |
56,765,711 |
RGD:6480464 |
CTD |
| G |
Cdc14b |
cell division cycle 14B |
|
increases expression |
ISO |
17 |
6,371,204 |
6,454,460 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
affects expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
|
increases expression |
EXP |
1 |
80,070,252 |
80,076,528 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
decreases expression |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
multiple interactions |
EXP |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
decreases expression |
EXP |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces3a |
carboxylesterase 3a |
|
multiple interactions |
EXP |
19 |
34,929,247 |
34,937,267 |
RGD:6480464 |
CTD |
| G |
Ces3a |
carboxylesterase 3a |
|
decreases expression |
EXP |
19 |
34,929,247 |
34,937,267 |
RGD:6480464 |
CTD |
| G |
Chad |
chondroadherin |
|
affects expression |
ISO |
10 |
83,201,982 |
83,205,753 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
increases expression |
EXP |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
decreases expression |
EXP |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Clcnka |
chloride channel, voltage-sensitive Ka |
|
affects expression |
ISO |
5 |
160,274,377 |
160,290,369 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
decreases expression |
EXP |
4 |
120,059,311 |
120,065,996 |
RGD:6480464 |
CTD |
| G |
Cnksr3 |
Cnksr family member 3 |
|
decreases expression |
EXP |
1 |
37,865,904 |
37,958,862 |
RGD:6480464 |
CTD |
| G |
Cnrip1 |
cannabinoid receptor interacting protein 1 |
|
decreases expression |
ISO |
14 |
97,908,407 |
97,937,729 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a5 |
collagen, type IV, alpha 5 |
|
decreases expression |
EXP |
X |
36,918,697 |
37,130,659 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
multiple interactions |
EXP |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
decreases expression |
EXP |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Cpa2 |
carboxypeptidase A2 (pancreatic) |
|
decreases expression |
EXP |
4 |
57,452,111 |
57,475,357 |
RGD:6480464 |
CTD |
| G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
|
affects expression |
ISO |
10 |
15,968,782 |
16,026,700 |
RGD:6480464 |
CTD |
| G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
|
decreases expression |
ISO |
4 |
48,295,056 |
48,568,314 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
EXP |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crip2 |
cysteine-rich protein 2 |
|
decreases expression |
EXP |
6 |
138,147,462 |
138,152,407 |
RGD:6480464 |
CTD |
| G |
Crlf1 |
cytokine receptor-like factor 1 |
|
decreases expression |
ISO |
16 |
19,431,472 |
19,442,747 |
RGD:6480464 |
CTD |
| G |
Crot |
carnitine O-octanoyltransferase |
|
increases expression |
EXP |
4 |
22,023,913 |
22,067,029 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
affects expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
increases expression |
EXP |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
affects expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
|
decreases expression |
ISO |
3 |
67,809,603 |
67,860,287 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cux2 |
cut-like homeobox 2 |
|
decreases expression |
ISO |
12 |
35,850,093 |
35,910,414 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
increases expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
decreases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl13 |
chemokine (C-X-C motif) ligand 13 |
|
multiple interactions |
EXP |
14 |
15,126,332 |
15,131,368 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases expression |
EXP |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
EXP |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases activity |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases activity |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases activity |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases response to substance |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
1 |
82,039,229 |
82,064,293 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases response to substance |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases activity |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
decreases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
decreases expression |
EXP |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
|
multiple interactions |
EXP |
5 |
116,744,337 |
116,766,822 |
RGD:6480464 |
CTD |
| G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
|
decreases expression |
EXP |
5 |
116,744,337 |
116,766,822 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
decreases expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
decreases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
decreases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dact2 |
dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis) |
|
decreases expression |
EXP |
1 |
53,084,115 |
53,093,031 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
1 |
213,081,825 |
213,095,034 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
increases expression |
EXP |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
decreases expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Defb1 |
defensin beta 1 |
|
increases expression |
EXP |
16 |
74,980,054 |
74,995,445 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
affects expression |
ISO |
3 |
51,521,343 |
51,543,552 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases expression |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
decreases expression |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dock7 |
dedicator of cytokinesis 7 |
|
decreases expression |
ISO |
5 |
119,377,149 |
119,535,973 |
RGD:6480464 |
CTD |
| G |
Dpm2 |
dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
multiple interactions |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp9 |
dual specificity phosphatase 9 |
|
decreases expression |
ISO |
X |
159,538,012 |
159,541,937 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
affects expression |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
E2f4 |
E2F transcription factor 4, p107/p130-binding |
|
affects expression |
ISO |
19 |
35,112,273 |
35,118,888 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
decreases expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehbp1 |
EH domain binding protein 1 |
|
decreases expression |
EXP |
14 |
102,732,009 |
102,951,294 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
affects expression |
ISO |
6 |
21,638,705 |
21,686,023 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
affects expression |
ISO |
18 |
40,808,057 |
40,819,421 |
RGD:6480464 |
CTD |
| G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
|
affects expression |
ISO |
X |
56,700,148 |
56,714,851 |
RGD:6480464 |
CTD |
| G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
affects expression |
ISO |
8 |
82,922,551 |
82,948,348 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
decreases expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
decreases expression |
EXP |
1 |
21,087,402 |
21,159,925 |
RGD:6480464 |
CTD |
| G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
decreases expression |
EXP |
1 |
21,087,402 |
21,159,925 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Esm1 |
endothelial cell-specific molecule 1 |
|
increases expression |
EXP |
2 |
44,626,010 |
44,634,748 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Exoc3 |
exocyst complex component 3 |
|
increases expression |
EXP |
1 |
29,897,536 |
29,928,281 |
RGD:6480464 |
CTD |
| G |
Exph5 |
exophilin 5 |
|
increases expression |
ISO |
8 |
56,762,507 |
56,835,516 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fam131b |
family with sequence similarity 131, member B |
|
decreases expression |
ISO |
4 |
70,082,502 |
70,091,693 |
RGD:6480464 |
CTD |
| G |
Fam69a |
family with sequence similarity 69, member A |
|
increases expression |
ISO |
14 |
2,326,255 |
2,397,029 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbln5 |
fibulin 5 |
|
increases expression |
EXP |
6 |
126,018,541 |
126,098,234 |
RGD:6480464 |
CTD |
| G |
Fbxo24 |
F-box protein 24 |
|
decreases expression |
ISO |
12 |
19,679,945 |
19,690,296 |
RGD:6480464 |
CTD |
| G |
Fbxw9 |
F-box and WD repeat domain containing 9 |
|
affects expression |
ISO |
19 |
24,746,820 |
24,753,726 |
RGD:6480464 |
CTD |
| G |
Fcar |
Fc fragment of IgA, receptor for |
|
increases expression |
ISO |
1 |
68,976,542 |
69,022,651 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
decreases expression |
ISO |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
decreases expression |
ISO |
5 |
115,881,466 |
116,286,358 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
decreases expression |
EXP |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
decreases expression |
EXP |
4 |
165,448,027 |
165,456,481 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin B, beta |
|
decreases expression |
EXP |
15 |
18,949,027 |
19,082,504 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Foxa3 |
forkhead box A3 |
|
affects expression |
ISO |
1 |
78,368,026 |
78,376,953 |
RGD:6480464 |
CTD |
| G |
Foxd4 |
forkhead box D4 |
|
decreases expression |
ISO |
1 |
228,348,202 |
228,349,654 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
decreases phosphorylation |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
increases expression |
ISO |
5 |
154,703,722 |
154,720,971 |
RGD:6480464 |
CTD |
| G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
|
decreases expression |
EXP |
1 |
86,095,551 |
86,098,079 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
ISO |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
decreases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
decreases expression |
EXP |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
decreases expression |
EXP |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
decreases expression |
EXP |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
decreases expression |
ISO |
3 |
14,485,028 |
14,559,484 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
multiple interactions |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
decreases expression |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
decreases expression |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
EXP |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
increases expression |
EXP |
5 |
172,341,135 |
172,386,772 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
affects expression |
ISO |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
decreases expression |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpr64 |
G protein-coupled receptor 64 |
|
decreases expression |
ISO |
X |
55,585,378 |
55,658,340 |
RGD:6480464 |
CTD |
| G |
Gpr68 |
G protein-coupled receptor 68 |
|
increases expression |
ISO |
6 |
125,134,284 |
125,174,033 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
decreases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
affects expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
affects expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
increases expression |
EXP |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
multiple interactions |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
decreases expression |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
decreases expression |
ISO |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
increases expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
decreases expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
increases expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
affects expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hipk2 |
homeodomain interacting protein kinase 2 |
|
increases expression |
ISO |
4 |
66,273,623 |
66,455,774 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hoxb2 |
homeobox B2 |
|
decreases expression |
EXP |
10 |
85,085,425 |
85,087,617 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
decreases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
multiple interactions |
EXP |
12 |
34,548,320 |
34,558,371 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
increases expression |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
decreases expression |
EXP |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
increases expression |
ISO |
2 |
193,500,916 |
193,507,633 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
increases expression |
ISO |
5 |
77,680,173 |
77,716,789 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
affects expression |
ISO |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam5 |
intercellular adhesion molecule 5, telencephalin |
|
increases expression |
ISO |
8 |
20,055,255 |
20,062,100 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
decreases expression |
EXP |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
EXP |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44-like |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il17rb |
interleukin 17 receptor B |
|
increases expression |
ISO |
16 |
5,335,806 |
5,349,160 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
affects expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
increases expression |
EXP |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
multiple interactions |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
decreases expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
multiple interactions |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
decreases expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
|
increases expression |
EXP |
18 |
63,809,336 |
63,840,069 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insl6 |
insulin-like 6 |
|
affects expression |
ISO |
1 |
232,990,534 |
232,994,069 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itga2b |
integrin, alpha 2B |
|
decreases expression |
EXP |
10 |
91,557,086 |
91,574,194 |
RGD:6480464 |
CTD |
| G |
Itga7 |
integrin, alpha 7 |
|
multiple interactions |
EXP |
7 |
2,230,747 |
2,269,403 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
decreases expression |
EXP |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itsn1 |
intersectin 1 (SH3 domain protein) |
|
decreases expression |
ISO |
11 |
31,721,528 |
31,901,963 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
affects activity |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
decreases expression |
ISO |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
decreases expression |
EXP |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Klrg1 |
killer cell lectin-like receptor subfamily G, member 1 |
|
decreases expression |
EXP |
4 |
158,673,698 |
158,684,674 |
RGD:6480464 |
CTD |
| G |
Kmo |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
|
decreases expression |
EXP |
13 |
91,363,517 |
91,394,174 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
decreases expression |
EXP |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
|
multiple interactions |
EXP |
6 |
94,270,120 |
94,280,916 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Leprel1 |
leprecan-like 1 |
|
decreases expression |
ISO |
11 |
76,687,437 |
76,828,785 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
|
affects expression |
ISO |
1 |
192,082,902 |
192,174,599 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
decreases expression |
EXP |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Limk2 |
LIM domain kinase 2 |
|
decreases expression |
EXP |
14 |
83,969,282 |
84,037,218 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
increases expression |
EXP |
8 |
62,083,052 |
62,106,827 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrfn1 |
leucine rich repeat and fibronectin type III domain containing 1 |
|
decreases expression |
ISO |
1 |
83,567,056 |
83,580,643 |
RGD:6480464 |
CTD |
| G |
Lrrc16a |
leucine rich repeat containing 16A |
|
affects expression |
ISO |
17 |
47,923,987 |
48,206,590 |
RGD:6480464 |
CTD |
| G |
Ltb4r2 |
leukotriene B4 receptor 2 |
|
decreases expression |
ISO |
15 |
33,923,472 |
33,924,548 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
affects expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Magee1 |
melanoma antigen, family E, 1 |
|
decreases expression |
ISO |
X |
93,192,218 |
93,195,765 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
decreases expression |
EXP |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
decreases expression |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
decreases expression |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
decreases expression |
ISO |
11 |
79,532,504 |
79,602,755 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
increases expression |
ISO |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mccc1 |
methylcrotonoyl-CoA carboxylase 1 (alpha) |
|
increases expression |
ISO |
2 |
122,416,660 |
122,469,557 |
RGD:6480464 |
CTD |
| G |
Mdfi |
MyoD family inhibitor |
|
decreases expression |
ISO |
9 |
8,623,038 |
8,641,388 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases phosphorylation |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases phosphorylation |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
|
decreases expression |
ISO |
1 |
146,220,504 |
146,422,659 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
affects expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mettl7b |
methyltransferase like 7B |
|
increases expression |
EXP |
7 |
2,269,393 |
2,272,039 |
RGD:6480464 |
CTD |
| G |
Mgat1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
EXP |
10 |
34,706,908 |
34,724,328 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
decreases expression |
ISO |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
multiple interactions |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
ISO |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mid1ip1 |
MID1 interacting protein 1 |
|
increases expression |
ISO |
X |
24,205,679 |
24,207,860 |
RGD:6480464 |
CTD |
| G |
Mmp11 |
matrix metallopeptidase 11 |
|
decreases expression |
ISO |
20 |
13,129,667 |
13,138,449 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
affects expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mrpl37 |
mitochondrial ribosomal protein L37 |
|
increases expression |
EXP |
5 |
128,135,417 |
128,145,916 |
RGD:6480464 |
CTD |
| G |
Ms4a4a |
membrane-spanning 4-domains, subfamily A, member 4A |
|
decreases expression |
ISO |
1 |
213,937,922 |
213,959,942 |
RGD:6480464 |
CTD |
| G |
Ms4a6a |
membrane-spanning 4-domains, subfamily A, member 6A |
|
decreases expression |
ISO |
1 |
214,046,885 |
214,057,578 |
RGD:6480464 |
CTD |
| G |
Msr1 |
macrophage scavenger receptor 1 |
|
decreases expression |
ISO |
16 |
56,278,223 |
56,345,472 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
decreases expression |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Myof |
myoferlin |
|
increases expression |
ISO |
1 |
242,209,178 |
242,372,206 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
EXP |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
decreases expression |
EXP |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ndufb9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 |
|
decreases expression |
EXP |
7 |
95,949,322 |
95,955,668 |
RGD:6480464 |
CTD |
| G |
Nefh |
neurofilament, heavy polypeptide |
|
decreases expression |
ISO |
14 |
85,594,789 |
85,604,774 |
RGD:6480464 |
CTD |
| G |
Neurl3 |
neuralized homolog 3 (Drosophila) |
|
increases expression |
EXP |
9 |
35,190,429 |
35,198,526 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
decreases expression |
EXP |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
affects expression |
ISO |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
EXP |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
decreases expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
increases expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Nipal2 |
NIPA-like domain containing 2 |
|
increases expression |
EXP |
7 |
70,021,792 |
70,135,156 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Npepo |
aminopeptidase O |
|
decreases expression |
EXP |
17 |
7,353,426 |
7,624,936 |
RGD:6480464 |
CTD |
| G |
Nptx1 |
neuronal pentraxin I |
|
increases expression |
ISO |
10 |
108,918,661 |
108,927,616 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
decreases expression |
EXP |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrp2 |
neuropilin 2 |
|
decreases expression |
ISO |
9 |
61,348,529 |
61,460,457 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
decreases expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
decreases expression |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Olr1366 |
olfactory receptor 1366 |
|
decreases expression |
EXP |
10 |
12,334,211 |
12,335,155 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
affects expression |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
decreases expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases activity |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
decreases expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
affects expression |
ISO |
13 |
87,059,476 |
87,083,085 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
increases expression |
ISO |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
decreases expression |
ISO |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pdlim2 |
PDZ and LIM domain 2 |
|
increases expression |
ISO |
15 |
50,564,108 |
50,575,871 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
multiple interactions |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
decreases expression |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pdzrn3 |
PDZ domain containing RING finger 3 |
|
affects expression |
ISO |
4 |
136,044,210 |
136,254,969 |
RGD:6480464 |
CTD |
| G |
Pfn2 |
profilin 2 |
|
increases expression |
ISO |
2 |
147,066,815 |
147,072,519 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
decreases expression |
EXP |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pla2g12a |
phospholipase A2, group XIIA |
|
affects expression |
ISO |
2 |
227,331,049 |
227,348,091 |
RGD:6480464 |
CTD |
| G |
Plb1 |
phospholipase B1 |
|
decreases expression |
ISO |
6 |
24,196,110 |
24,294,522 |
RGD:6480464 |
CTD |
| G |
Plekhf1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
|
increases expression |
ISO |
1 |
90,697,260 |
90,698,737 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
affects expression |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
multiple interactions |
EXP |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmm1 |
phosphomannomutase 1 |
|
affects expression |
ISO |
7 |
120,323,808 |
120,334,065 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
decreases expression |
EXP |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
|
decreases expression |
EXP |
10 |
96,120,205 |
96,130,221 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases expression |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases expression |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases expression |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Ppl |
periplakin |
|
decreases expression |
ISO |
10 |
10,566,823 |
10,612,474 |
RGD:6480464 |
CTD |
| G |
Ppox |
protoporphyrinogen oxidase |
|
decreases expression |
EXP |
13 |
87,170,602 |
87,174,740 |
RGD:6480464 |
CTD |
| G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
|
decreases expression |
EXP |
16 |
60,552,431 |
60,564,789 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
multiple interactions |
EXP |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
decreases expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
|
decreases expression |
EXP |
1 |
85,546,014 |
85,559,530 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
increases expression |
EXP |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
decreases expression |
EXP |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
affects expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
decreases expression |
EXP |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
|
decreases expression |
EXP |
6 |
122,840,062 |
122,910,939 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
decreases expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
decreases expression |
EXP |
5 |
138,671,725 |
138,739,002 |
RGD:6480464 |
CTD |
| G |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
|
decreases expression |
EXP |
9 |
74,528,095 |
74,542,756 |
RGD:6480464 |
CTD |
| G |
Pus1 |
pseudouridylate synthase 1 |
|
increases expression |
ISO |
12 |
46,024,978 |
46,033,733 |
RGD:6480464 |
CTD |
| G |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
|
decreases expression |
ISO |
1 |
212,474,632 |
212,482,280 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Ralb |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
|
increases expression |
EXP |
13 |
32,229,646 |
32,238,410 |
RGD:6480464 |
CTD |
| G |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
|
increases expression |
ISO |
2 |
170,472,420 |
170,587,987 |
RGD:6480464 |
CTD |
| G |
Rasal1 |
RAS protein activator like 1 (GAP1 like) |
|
increases expression |
ISO |
12 |
37,047,909 |
37,080,129 |
RGD:6480464 |
CTD |
| G |
Rasl10b |
RAS-like, family 10, member B |
|
decreases expression |
ISO |
10 |
71,492,903 |
71,503,357 |
RGD:6480464 |
CTD |
| G |
Rcn1 |
reticulocalbin 1, EF-hand calcium binding domain |
|
affects expression |
ISO |
3 |
90,832,151 |
90,846,395 |
RGD:6480464 |
CTD |
| G |
Resp18 |
regulated endocrine-specific protein 18 |
|
decreases expression |
EXP |
9 |
74,551,809 |
74,558,151 |
RGD:6480464 |
CTD |
| G |
RGD1303003 |
homolog of zebrafish ES1 |
|
increases expression |
ISO |
20 |
10,851,555 |
10,859,652 |
RGD:6480464 |
CTD |
| G |
Rgs8 |
regulator of G-protein signaling 8 |
|
increases expression |
EXP |
13 |
68,735,814 |
68,766,956 |
RGD:6480464 |
CTD |
| G |
Rho |
rhodopsin |
|
increases expression |
ISO |
4 |
152,057,788 |
152,062,950 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
decreases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnaset2 |
ribonuclease T2 |
|
affects expression |
ISO |
1 |
47,227,491 |
47,244,660 |
RGD:6480464 |
CTD |
| G |
Rnf151 |
ring finger protein 151 |
|
decreases expression |
ISO |
10 |
13,970,717 |
13,973,034 |
RGD:6480464 |
CTD |
| G |
Rnf207 |
ring finger protein 207 |
|
decreases expression |
ISO |
5 |
169,537,947 |
169,550,915 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
increases expression |
ISO |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
increases expression |
EXP |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
increases expression |
EXP |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Da |
RT1 class II, locus Da |
|
increases expression |
EXP |
20 |
4,636,310 |
4,641,282 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
decreases expression |
EXP |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
affects expression |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
affects expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scg5 |
secretogranin V (7B2 protein) |
|
affects expression |
ISO |
3 |
99,629,194 |
99,674,523 |
RGD:6480464 |
CTD |
| G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
affects expression |
ISO |
18 |
37,200,474 |
37,203,396 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
decreases expression |
EXP |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
affects expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
|
decreases expression |
ISO |
18 |
41,545,350 |
41,665,721 |
RGD:6480464 |
CTD |
| G |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
EXP |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
multiple interactions |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
decreases expression |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
multiple interactions |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
decreases expression |
EXP |
17 |
37,780,179 |
37,791,625 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
affects expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sertad2 |
SERTA domain containing 2 |
|
increases expression |
ISO |
14 |
101,372,813 |
101,445,258 |
RGD:6480464 |
CTD |
| G |
Sf3b4 |
splicing factor 3b, subunit 4 |
|
affects expression |
ISO |
2 |
190,976,681 |
190,981,433 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
decreases expression |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
|
decreases expression |
EXP |
3 |
153,849,825 |
153,890,111 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
multiple interactions |
EXP |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
decreases expression |
EXP |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
decreases expression |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases expression |
EXP |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc25a10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
|
increases expression |
EXP |
10 |
109,877,811 |
109,885,272 |
RGD:6480464 |
CTD |
| G |
Slc25a10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
|
decreases expression |
EXP |
10 |
109,877,811 |
109,885,272 |
RGD:6480464 |
CTD |
| G |
Slc27a3 |
solute carrier family 27 (fatty acid transporter), member 3 |
|
decreases expression |
ISO |
2 |
182,643,984 |
182,648,652 |
RGD:6480464 |
CTD |
| G |
Slc27a4 |
solute carrier family 27 (fatty acid transporter), member 4 |
|
affects expression |
ISO |
3 |
8,791,504 |
8,802,884 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases expression |
EXP |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases expression |
EXP |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
decreases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
decreases expression |
EXP |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
decreases expression |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc41a2 |
solute carrier family 41, member 2 |
|
increases expression |
EXP |
7 |
22,583,232 |
22,669,674 |
RGD:6480464 |
CTD |
| G |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
|
decreases expression |
EXP |
10 |
91,454,824 |
91,471,072 |
RGD:6480464 |
CTD |
| G |
Slc6a13 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
|
decreases expression |
EXP |
4 |
157,736,264 |
157,771,945 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
multiple interactions |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
decreases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
decreases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression |
ISO |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
decreases expression |
EXP |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
increases expression |
ISO |
1 |
156,992,492 |
157,028,887 |
RGD:6480464 |
CTD |
| G |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
|
increases expression |
ISO |
1 |
129,580,126 |
130,077,110 |
RGD:6480464 |
CTD |
| G |
Smarcb1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
|
affects expression |
ISO |
20 |
13,140,331 |
13,162,437 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sos1 |
Son of sevenless homolog 1 (Drosophila) |
|
increases expression |
ISO |
6 |
3,308,778 |
3,390,661 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
EXP |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 (hevin) |
|
increases expression |
EXP |
14 |
6,766,347 |
6,797,581 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp2 |
secreted phosphoprotein 2 |
|
decreases expression |
EXP |
9 |
87,297,052 |
87,316,546 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
multiple interactions |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
multiple interactions |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
multiple interactions |
EXP |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
affects expression |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
multiple interactions |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
decreases expression |
EXP |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
decreases expression |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sycn |
syncollin |
|
decreases expression |
EXP |
1 |
83,651,275 |
83,651,687 |
RGD:6480464 |
CTD |
| G |
Sympk |
symplekin |
|
decreases expression |
ISO |
1 |
78,377,890 |
78,407,581 |
RGD:6480464 |
CTD |
| G |
Synj2 |
synaptojanin 2 |
|
decreases expression |
EXP |
1 |
40,763,794 |
40,818,491 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
decreases expression |
EXP |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
increases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
increases expression |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
increases expression |
ISO |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
affects expression |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
decreases expression |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
affects expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
affects expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr6 |
toll-like receptor 6 |
|
decreases expression |
ISO |
14 |
46,089,365 |
46,100,687 |
RGD:6480464 |
CTD |
| G |
Tmem37 |
transmembrane protein 37 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmem47 |
transmembrane protein 47 |
|
decreases expression |
EXP |
X |
67,522,289 |
67,549,061 |
RGD:6480464 |
CTD |
| G |
Tmod1 |
tropomodulin 1 |
|
decreases expression |
ISO |
5 |
62,578,142 |
62,668,760 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
increases expression |
ISO |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
|
increases expression |
EXP |
9 |
13,587,961 |
13,666,380 |
RGD:6480464 |
CTD |
| G |
Tnfsf14 |
tumor necrosis factor (ligand) superfamily, member 14 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
EXP |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Tpra1 |
transmembrane protein, adipocyte asscociated 1 |
|
increases expression |
ISO |
4 |
123,001,474 |
123,006,178 |
RGD:6480464 |
CTD |
| G |
Tram2 |
translocation associated membrane protein 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
decreases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
increases expression |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tsku |
tsukushi, small leucine rich proteoglycan |
|
affects expression |
ISO |
1 |
155,611,069 |
155,622,378 |
RGD:6480464 |
CTD |
| G |
Tsnax |
translin-associated factor X |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
increases expression |
EXP |
7 |
121,597,084 |
121,599,342 |
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
decreases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ube2q2 |
ubiquitin-conjugating enzyme E2Q family member 2 |
|
increases expression |
ISO |
8 |
58,688,257 |
58,749,088 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
decreases expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
decreases expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases expression |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases expression |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases expression |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
|
decreases expression |
EXP |
14 |
22,154,370 |
22,178,222 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
increases expression |
ISO |
14 |
22,454,256 |
22,493,510 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil-DNA glycosylase |
|
decreases expression |
EXP |
12 |
43,520,629 |
43,528,873 |
RGD:6480464 |
CTD |
| G |
Uox |
urate oxidase |
|
decreases expression |
EXP |
2 |
244,795,552 |
244,832,143 |
RGD:6480464 |
CTD |
| G |
Upb1 |
ureidopropionase, beta |
|
decreases expression |
EXP |
20 |
13,715,995 |
13,743,261 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vil1 |
villin 1 |
|
increases expression |
ISO |
9 |
73,748,632 |
73,776,347 |
RGD:6480464 |
CTD |
| G |
Vrk3 |
vaccinia related kinase 3 |
|
increases expression |
ISO |
1 |
95,231,170 |
95,258,496 |
RGD:6480464 |
CTD |
| G |
Wdr76 |
WD repeat domain 76 |
|
increases expression |
ISO |
3 |
108,285,809 |
108,317,646 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
XAF1 |
XIAP associated factor-1 |
|
decreases expression |
ISO |
10 |
59,185,150 |
59,196,549 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
increases expression |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
multiple interactions |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
multiple interactions |
ISO |
4 |
125,672,674 |
125,699,925 |
RGD:6480464 |
CTD |
| G |
Zfp354a |
zinc finger protein 354A |
|
decreases expression |
EXP |
10 |
36,654,406 |
36,665,659 |
RGD:6480464 |
CTD |
| G |
Zfp395 |
zinc finger protein 395 |
|
increases expression |
ISO |
15 |
44,806,300 |
44,819,787 |
RGD:6480464 |
CTD |
| G |
Zfp697 |
zinc finger protein 697 |
|
decreases expression |
ISO |
2 |
193,237,465 |
193,241,657 |
RGD:6480464 |
CTD |
Term paths to the root
|